1301 transgenesis by lentiviral vectors: lack of gene silencing in mammalian ES cells and preimplantation embryos

1301 Transgenesis by Lentiviral Vectors Lack of Gene Silencing in Mammalian ES Cells and Preimplantation Embryos Molecular Therapy Vol 5, No 5, May 2002, Part 2 of 2 Parts Copyright © The American Soc[.]

"7" "!"!     E   E        -M=%  /                     1                  89                         -M=/    E  "55"#''           E   "55"                     )*)9            "55" '   E                  '>"   E   68±9; H  E     -H $/      -O99&/  95±9, H $        '>"   E  * G              =6±95 H $%  9;±98 H $%    D           ::±9:H$% 59±9=H$%                  H  '            "55"#''   "55"            (*)+()9  3                      E   "55"   '            ?         '           3                 1299 Control of Immune Responses to Gene Therapy: A Human CD80 Enhancer/Promoter Construct Enables Specific Ablation of Gene-T ransfected Antigen Gene-Transfected Presenting Cells In Vitro Yuanfang Liu,1 John R Rodgers.1 Immunology, Baylor College of Medicine, Houston, Texas, United States @             G                   3              "    -'!/       '      3                  '!  '!"                            3             3  ' -$ '/          '!       "    ->/     "    -!/        $:9 -2;8/                3             "    $:9!>"       ?   !   ->?!/   $ '  3         $:9"    -',9/       -@E >"$ '          ->?,/ 3    "                           ,5=       >?,     ,5=        3    3 ,5=">?,              ' "$:9%$ '            4  "         ' " $:9!>%$ '     3         3     $:9  ,5=%>?,                  $ '" 3         "     ' "$:9!>                    "7" "!"! 1300 Lentiviral V ectors Utilizing the Chicken β-Globin Vectors 5′HS4 Insulator and the Human Interferonα Scaffold Interferon-α Attachment Region for High Level and Sustained Factor VIII Gene Expression Ali Ramezani,1 Teresa S Hawley,1 Robert G Hawley.1 Hematopoiesis, American Red Cross Holland Laboratory, Rockville, Maryland, United States C '    .-./                                     8"&H     .                "  3     .       1  '              '       -C(/                                          .                    @    -          /                      C( C   E         "           "           "                             $*'         3         "       3           β" &VC(6         "α      -?*"('@/                   G          -@ G   #  ,76:&"65B ,999/          ->?8α/   -4=    #(. D @/     -'/       3               ->?!/               3      $=6J        A8(    "           "   G         >?!     3                 )              &VC(6      ?*"('@                3                                                    #(. 4= D @    1    1           $=6J                 %                       (         A8    3     >?!                   2                       &VC(6       ?*"('@   3    "     . $*'                     C(          ."     D"  .     3                                               1301 T ransgenesis by Lentiviral V ectors: Lack of Transgenesis Vectors: Gene Silencing in Mammalian ES Cells and Preimplantation Embryos Alexander Pfeifer, Masahito Ikawa, Yelena Dayn, Inder M Verma @                       ->(/                      C                               3                                    ?   "      -?'(/ 3       86          >(             ?! 3               '    -D." ?!/    ?! 3   5&&H      >             D."?!     >(   3 ?! 3         3    " Molecular Therapy Vol 5, No 5, May 2002, Part of Parts Copyright © The American Society of Gene Therapy S425 "7" "!"!                D."?!"      >(            3             >              3                      G            >(          '  >(                    3               * 3   G                          -   /                  3                    "                       "       '  - 8,/      3           ?            -  ?!/ 3                                               >(         '            >(                  "    1302 Development of B Lineage Specific Lentiviral Vectors for Use in Gene Therapy of Human B Lymphocyte Disorders Maria I Garcia-Lloret,1 Keun Chae,1 Ruby Tabuchi,1 Carolyn Lutzko,2 Don Khon,2 David J Rawlings.1 Department of Pediatrics, UCLA, Los Angeles, California, United States; 2Children′s Hospital, Los Angeles, California, United States              " -(*/           3                 2                    -C(/        2      '    (*                ?!           '  7       ?!         3               I 3    2    "    -C2"D /        C(I   3     C(          2 #.   !A     3    -TB  / 3                  ->/              ?! 3   ="&                  $;5 -  I 2,5/    3      2      3  '   >2,5               ?! 3   2       3          #           -  #)/    1             &"89         ?!     2                  *2,5   3      2   - 2O 2O  2M  2/  C2"D           >2,5  - >!A >#./           ?! 3    -,9"&9H  89",&H/            3  -#? :99"8=99  =99"B99/ C"   3     2        #J   2          8,    C2"D  ($% *)$  C(                           * 3      ?! 3         $ 85J  -2   /    >2,5                ?!    1     $85J $==J-  /           >!A   >#.                  >2,5                   3                          2     S426 1303 Optimization of HIV -1 Based Lentiviral V ectors HIV-1 Vectors for Gene-Modification of Leukemia Cells Aaron C Logan,1, Donald B Kohn.1, Division of Research Immunology/Bone Marrow Transplantation, Childrens Hospital Los Angeles, Los Angeles, CA, United States; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States D                    "                                       #                3            "       E                           )                             3                  C."8                         ##D.                      G         "   3                                  -!! /            C."8                                               "               !!                                        "    3          !!                                        #)  !! J  !! "        ?!         G         8,                        3         !! J         "  3  8,",6      !! "     2                          !!                     "  3     1               3             #.                  4=    #!(.                                 3     6"8,    2     =",&           ,"=        (               !! &V                          3  -6"8:H   / '            (.69    D @   3              -≤&9H   / '          3           0!@>                           3  2                !!    (.69                       3                1304 T ectors Transcriptional Targeting Vectors ranscriptional T argeting of Lentiviral V TR Enhancer Replacement LTR by L Francesco Lotti,1 Emilio Menguzzato,1 Luigi Naldini,2 Fulvio Mavilio,1 Giuliana Ferrari.1 San Raffaele-Telethon Institute for Gene Therapy (HSR-TIGET), Istituto Scientifico H.S.Raffaele, Milano, Italy; 2Institute for Cancer Research and Treatment, University of Torino Medical School, Torino, Italy           1           "         -C(/         3          C."                     "              "                                       D @           " Molecular Therapy Vol 5, No 5, May 2002, Part of Parts Copyright © The American Society of Gene Therapy ... 1299 Control of Immune Responses to Gene Therapy: A Human CD80 Enhancer/Promoter Construct Enables Specific Ablation of Gene- T ransfected Antigen Gene- Transfected Presenting Cells In Vitro Yuanfang... Presenting Cells In Vitro Yuanfang Liu,1 John R Rodgers.1 Immunology, Baylor College of Medicine, Houston, Texas, United States @             G